WASHINGTON, Sept. 30 The Medical Device Manufacturers Association (MDMA) will hold its annual Coverage, Reimbursement and Health Policy Conference November 11-12 in Washington, DC. The meeting will bring together key officials from both the private and public sector to discuss the latest trends and policies surrounding reimbursement.
(Logo: http://www.newscom.com/cgi-bin/prnh/20041004/MDMALOGO )
Attendees at this year's conference will hear from critical decision makers in the field including Marc Hartstein, Acting Deputy Director, Hospital and Ambulatory Policy Group, Center for Medicare Management, CMS, and Tony Maida, Tony Maida, Deputy Chief, Administrative and Civil Remedies Branch, Office of Counsel to the Inspector General, HHS. In addition, issues of current reimbursement importance will be covered such as coding reform efforts, payment for new technologies, and international reimbursement systems.
"The MDMA Reimbursement Conference provides attendees a unique opportunity to interact with leaders in the field as well as key decision makers" said Mark Leahey, Executive Director of MDMA. "With the constant innovation and development of new, life-saving medical technologies, the Conference provides timely and essential information for companies seeking reimbursement as well as those companies hoping to improve their reimbursement strategies."
More information on the agenda, venue, accommodations and pricing can be found online at www.medicaldevices.org, or by calling MDMA's Director of Membership and Programs, Erin Jones, at (202) 354-7172.
The Medical Device Manufacturers Association (MDMA) is a national trade association based in Washington, D.C., representing innovators and entrepreneurs in the medical device industry. MDMA seeks to improve the quality of patient care by encouraging the development of new medical technology and fostering the availability of innovative products in the marketplace.
SOURCE Medical Device Manufacturers Association